$BCTX project team announces a major breakthrough: BriaCell's Bria-OTS™ clinical trial has achieved another breakthrough, with patients experiencing sustained complete remission of lung metastases. What does this medical milestone mean? It offers new hope for advanced patients unresponsive to standard therapies. From an investment perspective, clinical results of innovative biopharmaceutical projects are often the key trigger for valuation re-evaluation. The project continues to advance, and the fundamentals are being gradually validated.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
14 Likes
Reward
14
7
Repost
Share
Comment
0/400
LiquidationWatcher
· 1h ago
It's already worth it that late-stage patients can see hope, but how much longer do we have to wait for the official launch...
View OriginalReply0
MidnightSnapHunter
· 11h ago
Another breakthrough in cancer therapy, late-stage patients have a chance, this is true technological innovation
View OriginalReply0
GasOptimizer
· 11h ago
Complete remission? That's the real breakthrough, not just superficial numbers on paper.
View OriginalReply0
ProposalDetective
· 11h ago
Lung metastasis sustained complete remission? If this really gets mass-produced and implemented, it would be amazing, but it's still too early to say that now.
View OriginalReply0
MonkeySeeMonkeyDo
· 11h ago
Complete remission of pulmonary metastasis, which is indeed good. But let's wait for FDA approval first; there are many biotech and pharmaceutical projects with impressive clinical data.
View OriginalReply0
MemeCurator
· 11h ago
Another new breakthrough in tumor therapy, this time it really seems to have some substance.
View OriginalReply0
metaverse_hermit
· 12h ago
Bro, is this data real? Why does it always say breakthrough...
$BCTX project team announces a major breakthrough: BriaCell's Bria-OTS™ clinical trial has achieved another breakthrough, with patients experiencing sustained complete remission of lung metastases. What does this medical milestone mean? It offers new hope for advanced patients unresponsive to standard therapies. From an investment perspective, clinical results of innovative biopharmaceutical projects are often the key trigger for valuation re-evaluation. The project continues to advance, and the fundamentals are being gradually validated.